Summary
Quest Diagnostics' 2014 10-K highlights a strategic turnaround, focusing on restoring growth through various initiatives including sales and marketing excellence, growing esoteric testing, and pursuing professional lab services partnerships. The company emphasizes driving operational excellence and cost savings, exemplified by the "Invigorate" program which delivered over $200 million in savings in 2014 and achieved over $700 million in run-rate savings compared to 2011, with a new goal of an additional $600 million in run-rate savings by 2017. Financially, the company is committed to disciplined capital deployment, returning free cash flow to investors via dividends and share repurchases. In January 2015, they announced a 15% dividend increase. Strategic acquisitions remain a key growth driver, with approximately $1 billion invested in seven acquisitions since 2012, including Solstas Lab Partners and Summit Health in 2014. The company positions itself as a leader in diagnostic information services, leveraging its scale, innovation, quality focus, and cost-effectiveness. It is actively innovating in areas like precision medicine, as demonstrated by the OncoVantage™ solution, and expanding its service offerings to address growing healthcare needs.
Financial Highlights
57 data points| Revenue | $7.43B |
| Cost of Revenue | $4.64B |
| Gross Profit | $2.80B |
| SG&A Expenses | $1.73B |
| Operating Expenses | $6.45B |
| Operating Income | $983.00M |
| Interest Expense | $167.00M |
| Net Income | $556.00M |
| EPS (Basic) | $3.83 |
| EPS (Diluted) | $3.81 |
| Shares Outstanding (Basic) | 145.00M |
| Shares Outstanding (Diluted) | 145.00M |
Key Highlights
- 1Quest Diagnostics is executing a five-point strategy: Restore Growth, Drive Operational Excellence, Simplify the Organization, Refocus on Diagnostic Information Services, and Deliver Disciplined Capital Deployment.
- 2The company achieved significant cost savings through its "Invigorate" program, delivering over $200 million in realized savings in 2014 and exceeding its run-rate savings goal.
- 3Quest Diagnostics is actively pursuing growth through strategic acquisitions, having invested approximately $1 billion in seven acquisitions since 2012.
- 4Capital deployment includes returning free cash flow to shareholders through dividends and share repurchases, with a 15% dividend increase announced in January 2015.
- 5The company is investing in innovation, particularly in diagnostic information services and the growing field of precision medicine, highlighted by the launch of OncoVantage™.
- 6Quest Diagnostics maintains a strong market position due to its unmatched size, scale, broad test menu, and extensive nationwide network.
- 7The company is streamlining its organization to improve efficiency and focus on growth opportunities.